Showing results (411-420 of 527) with videos related to
Sort By:
Pageof 53
RMD Open|September 1, 2018
Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trialPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.Bioorganic & Medicinal Chemistry Letters|September 28, 2016
Identification and optimization of a new series of anti-tubercular quinazolinonesCédric Couturier, Christine Lair, Alain Pellet, et al.Retina (Philadelphia, Pa.)|January 31, 2015
Multifocal electroretinogram in birdshot chorioretinopathyChristophe Chiquet, Sylvie Berthemy-Pellet, Joséphine Altayrac-Bethenod, et al.ACR Open Rheumatology|January 17, 2020
Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 StudyPhilip J Mease, Arthur Kavanaugh, Andreas Reimold, et al.BMC Psychiatry|September 21, 2006
Schizophrenia and quality of life: a one-year follow-up in four EU countriesViviane Kovess-Masféty, Miguel Xavier, Berta Moreno Kustner, et al.Cells|May 3, 2014
Endosome-to-Plasma Membrane Recycling of VEGFR2 Receptor Tyrosine Kinase Regulates Endothelial Function and Blood Vessel FormationHelen M Jopling, Adam F Odell, Caroline Pellet-Many, et al.Seminars in Nuclear Medicine|July 10, 2021
Impact of COVID-19 on Nuclear Medicine Departments in Africa and Latin AmericaFrancesco Giammarile, Roberto C Delgado Bolton, Noura El-Haj, et al.World Journal of Nuclear Medicine|November 12, 2025
Global Challenges in the Provision of Theranostic Services the International Atomic Energy Agency (IAEA) PerspectiveAnita Brink, Juliano J Cerci, Francesco Giammarile, et al.Bioorganic & Medicinal Chemistry|May 15, 2007
Synthesis and evaluation of new arylbenzo[b]thiophene and diarylthiophene derivatives as inhibitors of the NorA multidrug transporter of Staphylococcus aureusJérémie Fournier Dit Chabert, Béatrice Marquez, Luc Neville, et al.Journal of Medicinal Chemistry|May 18, 2012
Disulfide prodrugs of albitiazolium (T3/SAR97276): synthesis and biological activitiesSergio A Caldarelli, Matthieu Hamel, Jean-Frédéric Duckert, et al.Pageof 53